Skip to main content
. 2011 Oct;13(10):980–990. doi: 10.1593/neo.11916

Figure 5.

Figure 5

Effects of neoadjuvant treatment on circulating CD45- CD31- CD146+ cells in pancreatic cancer patients. Viable (A, B) and dead (C, D) cell counts as established for the indicated time points of blood withdrawal are presented by box plot for the entire study collective n = 20 (A, C) or separately for treatment arms n1 = 9 and n2 = 11 (B, D). Sampling points after gemcitabine administration are indicated by closed triangles placed between plots.